STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $84.6K priced
What the filings say about PROV
Insiders, 180 days
-$131.8K net sold
1 seller · 0% of sales under a 10b5-1 plan
Provident Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PROVIDENT FINANCIAL HOLDINGS INC insiders sold a net $131.8K of stock across 7 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Jun 10, 2025.
The trade is 23.4% of the 20,537 shares held after it.
No other insider sold within 30 days.
Insider activity: Senior Vice President Wertz Gwendolyn sold about $75.1K of PROV on Nov 12, 2025, the largest insider sale at the company on our record.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$8.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM PROV
FY Jun 2026
$8.5M
FY Jun 2025
$8.2M
FY Jun 2024
$4.1M
FY Jun 2023
$15.6M
FY Jun 2022
$11.6M
Jun 2026
$3.3M
Mar 2026
$1.7M
Dec 2025
$1.0M
Sep 2025
$2.5M
Jun 2025
$2.2M
Mar 2025
$3.3M
Dec 2024
$307.0K
Sep 2024
$2.4M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity PROV
FY Jun 2026
+5.2%
FY Jun 2025
+4.8%
FY Jun 2024
+5.7%
FY Jun 2023
+6.7%
FY Jun 2022
+7.1%
Jun 2026
+5.2%
Mar 2026
+4.8%
Dec 2025
+5.2%
Sep 2025
+4.7%
Jun 2025
+4.8%
Mar 2025
+5.1%
Dec 2024
+4.8%
Sep 2024
+5.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets PROV
FY Jun 2026
+0.5%
FY Jun 2025
+0.5%
FY Jun 2024
+0.6%
FY Jun 2023
+0.7%
FY Jun 2022
+0.8%
Jun 2026
+0.5%
Mar 2026
+0.5%
Dec 2025
+0.5%
Sep 2025
+0.5%
Jun 2025
+0.5%
Mar 2025
+0.5%
Dec 2024
+0.5%
Sep 2024
+0.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.63x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing PROV
FY Jun 2026
16.70x
FY Jun 2025
16.49x
FY Jun 2024
11.68x
FY Jun 2023
10.62x
FY Jun 2022
12.26x
Jun 2026
16.70x
Mar 2026
17.33x
Dec 2025
15.91x
Sep 2025
17.31x
Jun 2025
16.49x
Mar 2025
14.89x
Dec 2024
17.29x
Sep 2024
13.05x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value PROV
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield PROV
FY Jun 2026
+7.9%
FY Jun 2025
+7.9%
FY Jun 2024
+4.8%
FY Jun 2023
+17.4%
FY Jun 2022
+10.8%
Jun 2026
+7.9%
Mar 2026
+7.2%
Dec 2025
+8.7%
Sep 2025
+7.9%
Jun 2025
+7.9%
Mar 2025
+5.3%
Dec 2024
+4.1%
Sep 2024
+3.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.84x
P/E over trailing EPS growth of 10%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing PROV
FY Jun 2026
1.74x
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
0.62x
Jun 2026
1.74x
Mar 2026
n/a
Dec 2025
1.83x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PROV ranks highest on risk and compliance (79th percentile) and insider conviction (28th), and lowest on profitability (18th), among Banks peers.
Profitability
18
Inputs
Return on equity+5.2% · 19 pct, sector of 327
Return on assets+0.5% · 17 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$132K · 56 pct, sector of 274
Insider buyers, 180d0 · 0 pct, sector of 274
Risk and compliance
79
Inputs
Short interest, % of float+0.5% · 79 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Financial health, Growth, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PROV filings, in plain words
Are Provident Financial insiders buying or selling PROV?
In the 180 days to 2026-10-28, Provident Financial insiders were net sellers, a net $131.8K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Provident Financial insiders were net sellers of PROV, a net $131.8K across purchases and sales reported on Form 4 by 1 seller. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.